glp 1 bmi requirements and GLP-1 Weight Loss Treatment: What BMI Qualifies? Indications for GLP-1/GIP RA Summary
Description
insulin is the mainstay therapy
For GLP-1 Users: GLP-1 medications actively slow gastric emptying, frequently leading to stubborn constipation
The second study analyzed the effect of a monoclonal antibody that inhibits muscle mass loss, but found limited benefit
A massive study of veterans suggests these medications may quiet cravings far beyond food.
While GLP-1 agonist therapy medications have been marketed as diabetes treatments before, Mounjaro also has the action of glucose-dependent insulinotropic polypeptide (GIP)
